Identification of Novel EXT Mutations in Patients with Hereditary Multiple Exostoses Using Whole‐Exome Sequencing

To find novel potential gene mutations other than EXT1 and EXT2 mutations, to expand the mutational spectrum of EXT and to explore the correlation between clinical outcome and genotype in patients with hereditary multiple exostoses (HME).

[1]  R. Capanna,et al.  Hereditary Multiple Exostoses: Current Insights , 2019, Orthopedic research and reviews.

[2]  Qi-hua Fu,et al.  Heterogeneous spectrum of EXT gene mutations in Chinese patients with hereditary multiple osteochondromas , 2018, Medicine.

[3]  A. Jelin,et al.  Whole Exome Sequencing: Applications in Prenatal Genetics. , 2018, Obstetrics and gynecology clinics of North America.

[4]  M. Pacifici The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[5]  Tingting Yu,et al.  A genotype-phenotype study of hereditary multiple exostoses in forty-six Chinese patients , 2017, BMC Medical Genetics.

[6]  Zhenlin Zhang,et al.  Identification of mutations in EXT1 and EXT2 genes in six Chinese families with multiple osteochondromas. , 2017, Molecular medicine reports.

[7]  M. Abouelhoda,et al.  Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families , 2017, Scientific Reports.

[8]  Koenraad Devriendt,et al.  Prenatal and pre-implantation genetic diagnosis , 2016, Nature Reviews Genetics.

[9]  Zhenlin Zhang,et al.  Mutation screening for the EXT1 and EXT2 genes in Chinese patients with multiple osteochondromas. , 2013, Archives of medical research.

[10]  Enrico Ferrari,et al.  Validation of a new multiple osteochondromas classification through Switching Neural Networks , 2013, American journal of medical genetics. Part A.

[11]  Fenglan Peng,et al.  Mutation screening of EXT genes in Chinese patients with multiple osteochondromas. , 2012, Gene.

[12]  D. Jong,et al.  Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT , 2012, Oncogene.

[13]  E. Pignotti,et al.  Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors. , 2011, The Journal of bone and joint surgery. American volume.

[14]  M. Wiweger,et al.  Tiling resolution array‐CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients , 2011, Human mutation.

[15]  S. Stringer,et al.  No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. , 2010, The American journal of pathology.

[16]  S. Mackem,et al.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses , 2010, Proceedings of the National Academy of Sciences.

[17]  L. Sangiorgi,et al.  Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb) , 2009, Human mutation.

[18]  L. Kjellén,et al.  Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation* , 2007, Journal of Biological Chemistry.

[19]  A. Monaco,et al.  Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. , 2004, The Journal of bone and joint surgery. British volume.

[20]  C. McCormick,et al.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  F. Speleman,et al.  Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. , 1998, Genomics.

[22]  E. Wijsman,et al.  Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses , 1998, Human mutation.

[23]  B. Trask,et al.  Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. , 1997, Genome research.

[24]  B. D. de Vries,et al.  Positional cloning of a gene involved in hereditary multiple exostoses. , 1996, Human molecular genetics.

[25]  M. Wagner,et al.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1) , 1995, Nature Genetics.

[26]  R. Pauli,et al.  Natural history study of hereditary multiple exostoses. , 1995, American journal of medical genetics.